{
    "title": "Prion Disinfection Solution",
    "inventor_name": "Alex Sava",
    "publication_year": 2009,
    "device_name": "Asepti RAPIDZYME Pr",
    "goal": "Deactivate prions on medical instruments to prevent transmission of prion diseases such as Creutzfeldt-Jacob disease.",
    "problem_addressed": "Prion contamination of surgical and medical instruments; prions are highly resistant to heat and conventional chemical sterilisation.",
    "concept_summary": "An enzymatic cleaning solution that combines proteolytic enzymes with agents that promote conformational unfolding of the prion protein, breaking it into non-infectious fragments while remaining compatible with standard instrument cleaning equipment.",
    "detailed_description": "Novapharm Research, in collaboration with the University of Melbourne, developed a formulation based on naturally occurring enzymes that specifically cleave the PrP^Sc prion protein. The composition also contains agents that favour unfolding of the prion's structure without denaturing the enzymes. The solution can be used as a pre-cleaner in existing cleaning protocols for flexible endoscopes, neurosurgical, dental and ophthalmological instruments. It has received approval from the Australian Therapeutic Goods Administration and CE certification for EU distribution, and is marketed under the trade names Asepti RAPIDZYME Pr and Asepti AUTOZYME Pr.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Proteolytic enzymatic cleavage",
        "Conformational unfolding of protein",
        "Selective targeting of prion protein",
        "Compatibility with existing cleaning equipment"
    ],
    "scientific_domains": [
        "Biochemistry",
        "Molecular Biology",
        "Medical Technology"
    ],
    "mechanisms_of_action": [
        "Enzymatic cleavage of PrP^Sc into low-molecular-weight fragments",
        "Chemical agents induce conformational unfolding of prion protein",
        "Preservation of enzyme activity during cleaning"
    ],
    "materials": [
        "Proteolytic enzymes (natural origin)",
        "Conformational unfolding agents (chemical additives)"
    ],
    "energy_sources": [],
    "inputs": [
        "Contaminated medical instruments",
        "Water or cleaning solution carrier",
        "Standard cleaning equipment"
    ],
    "outputs": [
        "Decontaminated instruments safe for reuse",
        "Non-infectious protein fragments"
    ],
    "claimed_performance": "Cost-effective, highly effective pre-cleaner compatible with any surgical or medical instrument; does not disrupt current surgical procedures.",
    "experimental_evidence": "Regulatory approval (Australian Therapeutic Goods Administration) and CE certification indicate compliance with safety and efficacy standards, but no quantitative performance data are provided in the article.",
    "replication_status": null,
    "keywords": [
        "prion",
        "disinfection",
        "enzyme",
        "sterilisation",
        "medical instruments",
        "CJD",
        "Asepti RAPIDZYME"
    ],
    "related_technologies": [
        "Autoclaving",
        "Chemical sterilants (e.g., peracetic acid)",
        "Hydrogen peroxide plasma sterilisation",
        "Standard instrument cleaning protocols"
    ],
    "controversy_level": "low",
    "confidence_score": 0.9,
    "practicability_score": 0.85,
    "fringe_score": 0.1,
    "evidence_strength": 0.3,
    "risk_score": 0.2,
    "trl_estimate": 7,
    "source_urls": [
        "http://www.sciencealert.com.au/news/20091310-19987-2.html",
        "http://www.internetchemie.info/news/2008/jun08/index-en.html"
    ],
    "organizations": [
        "Novapharm Research (Australia) Pty Ltd",
        "University of Melbourne",
        "Australian Therapeutic Goods Administration"
    ],
    "applications": [
        "Hospital instrument reprocessing",
        "Veterinary surgical instrument cleaning",
        "Dental instrument sterilisation",
        "General medical device decontamination"
    ],
    "limitations": [
        "No quantitative efficacy data presented",
        "Potential variability in effectiveness against different prion strains",
        "Reliance on proper handling and protocol adherence"
    ],
    "open_questions": [
        "Long-term stability of the enzymatic formulation",
        "Efficacy against all known prion variants",
        "Compatibility with all instrument materials over repeated cycles"
    ],
    "red_flags": [],
    "evidence_quotes": [
        "Australian researchers have created a solution to deactivate prions, which are rogue, infectious proteins that cause Creutzfeldt-Jacob disease (CJD) and can be transmitted via surgical instruments.",
        "The solutions are derived from naturally occurring enzymes which have been specifically formulated to attack the structure of prions while maintaining characteristics which allow use as a general pre-cleaner of surgical and medical instruments.",
        "Novapharms prion deactivating solutions have been approved by the Australian Therapeutic Goods Administration and have full CE certification for distribution in the European Union.",
        "The outcome is cost effective, will enable all medical instruments to be treated against prions, will not disrupt current surgical procedures and is easily incorporated into current cleaning protocols.",
        "The new instrument reprocessing solutions developed by Novapharm can also be cost effective for hospitals, GPs, dentists, and vets since they will work with existing cleaning equipment and are highly effective as a general pre-cleaner compatible with any surgical or medical instruments."
    ]
}